7-150958110-C-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_000238.4(KCNH2):​c.865G>A​(p.Glu289Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,296,770 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

7
4
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:10O:1

Conservation

PhyloP100: 1.69
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High AC in GnomAd4 at 14 AD,Digenic gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNH2NM_000238.4 linkuse as main transcriptc.865G>A p.Glu289Lys missense_variant 4/15 ENST00000262186.10 NP_000229.1 Q12809-1Q15BH2A0A090N8Q0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNH2ENST00000262186.10 linkuse as main transcriptc.865G>A p.Glu289Lys missense_variant 4/151 NM_000238.4 ENSP00000262186.5 Q12809-1
KCNH2ENST00000532957.5 linkuse as main transcriptn.1088G>A non_coding_transcript_exon_variant 4/92
KCNH2ENST00000684241.1 linkuse as main transcriptn.1698G>A non_coding_transcript_exon_variant 2/13

Frequencies

GnomAD3 genomes
AF:
0.0000922
AC:
14
AN:
151874
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.0000946
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000589
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000255
AC:
1
AN:
3916
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2326
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000599
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000196
AC:
224
AN:
1144896
Hom.:
0
Cov.:
31
AF XY:
0.000179
AC XY:
98
AN XY:
548150
show subpopulations
Gnomad4 AFR exome
AF:
0.0000865
Gnomad4 AMR exome
AF:
0.000109
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000378
Gnomad4 SAS exome
AF:
0.0000277
Gnomad4 FIN exome
AF:
0.0000388
Gnomad4 NFE exome
AF:
0.000220
Gnomad4 OTH exome
AF:
0.000150
GnomAD4 genome
AF:
0.0000922
AC:
14
AN:
151874
Hom.:
0
Cov.:
33
AF XY:
0.000135
AC XY:
10
AN XY:
74170
show subpopulations
Gnomad4 AFR
AF:
0.000169
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.0000946
Gnomad4 NFE
AF:
0.0000589
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000110

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:4
Uncertain significance, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Uncertain significance, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJun 29, 2023Reported in association with LQTS and sudden infant death syndrome; however, no detailed clinical information was provided (Hedley et al., 2009; Tester et al., 2018); Published functional studies suggest that this variant does not significantly impact protein expression (Perry et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28988457, 19862833, 32048431, 35932045, 29544605, 26958806) -
Long QT syndrome Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 27, 2024This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 289 of the KCNH2 protein (p.Glu289Lys). This variant is present in population databases (rs199472880, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of KCNH2-related conditions (PMID: 19862833, 19926013). ClinVar contains an entry for this variant (Variation ID: 67535). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change does not substantially affect KCNH2 function (PMID: 26958806). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteMay 29, 2017- -
Long QT syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaJun 25, 2015- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpSep 23, 2021Variant summary: KCNH2 c.865G>A (p.Glu289Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00026 in 3916 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.865G>A has been reported in the literature in individuals affected with Arrhythmia (Hedley_2009, Shimizu_2009, Tester_2018). These reports do not provide unequivocal conclusions about association of the variant with Arrhythmia. At least one publication reports experimental evidence and showed no effect of this variant on protein expression (Perry_2016). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 28, 2022The c.865G>A (p.E289K) alteration is located in exon 4 (coding exon 4) of the KCNH2 gene. This alteration results from a G to A substitution at nucleotide position 865, causing the glutamic acid (E) at amino acid position 289 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Short QT syndrome type 1;C3150943:Long QT syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Congenital long QT syndrome Other:1
not provided, no classification providedliterature onlyCardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust-This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19862833). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.70
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Pathogenic
0.38
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.40
T;T
Eigen
Benign
-0.078
Eigen_PC
Benign
0.039
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Pathogenic
0.94
D
MetaRNN
Uncertain
0.74
D;D
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Benign
0.73
N;.
PrimateAI
Pathogenic
0.97
D
PROVEAN
Benign
-1.5
N;.
REVEL
Pathogenic
0.69
Sift
Benign
0.12
T;.
Sift4G
Benign
0.48
T;T
Polyphen
0.37
B;.
Vest4
0.52
MutPred
0.76
Gain of MoRF binding (P = 0.0028);.;
MVP
1.0
MPC
1.2
ClinPred
0.12
T
GERP RS
3.8
Varity_R
0.23
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199472880; hg19: chr7-150655198; COSMIC: COSV100061559; COSMIC: COSV100061559; API